1. International Diabetes Foundation. IDF Diabetes Atlas, 6th edn. Available from
http://www.idf.org/diabetesatlas
(cited 6 December 2012)..
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C . American Heart A Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.
3. Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B, Lawrence A et al. Effects of Omega-3 Fatty Acids on Cardiovascular Risk Factors and Intermediate Markers of Cardiovascular Disease. Summary, Evidence Report/Technology Assessment: Number 93. AHRQ Publication Number 04-E010-1. Agency for Healthcare Research and Quality: Rockville, MD, 2004.
http://www.ahrq.gov/clinic/epcsums/o3cardrisksum.htm
.
4. Zhang G, Sun Q, Hu FB, Ye X, Yu Z, Zong G et al. Erythrocyte n-3 fatty acids and metabolic syndrome in middle-aged and older Chinese. J Clin Endocrinol Metab 2012; 97: E973–E977.
5. Huang T, Bhulaidok S, Cai Z, Xu T, Xu F, Wahlqvist ML et al. Plasma phospholipids n-3 polyunsaturated fatty acid is associated with metabolic syndrome. Mol Nutr Food Res 2010; 54: 1628–1635.